| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 99,765 | 101,300 | 75,371 | 104,097 | | Cost of Revenue | (125,733) | 67,164 | 58,569 | 65,492 | | | Gross Profit | 225,498 | 34,136 | 16,802 | 38,605 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 197,806 | 5,899 | 5,685 | 5,387 | | Non Recurring | 2 | 67,667 | 7 | 651,122 | | Others | 4,120 | 4,224 | 4,316 | 4,433 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,421 | (43,654) | 6,794 | (622,337) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,001 | 8,382 | 8,143 | 3,031 | | Earnings Before Interest And Taxes | 26,571 | (35,272) | 14,937 | (619,306) | | Interest Expense | 7,856 | 7,859 | 8,113 | 10,209 | | Income Before Tax | 18,715 | (43,131) | 6,824 | (629,515) | | Income Tax Expense | 440 | (1,218) | 1,488 | (200,293) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,275 | (41,913) | 5,336 | (429,222) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (582) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,275 | (41,913) | 5,336 | (429,804) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,275 | ($41,913) | $5,336 | ($429,804) |
|
0.26% Nasdaq 
0.40 (5.29%) 
Income Statement
